Cargando…

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer

The Polycomb protein enhancer of zeste homolog 2 (EZH2) is frequently overexpressed in advanced human prostate cancer (PCa), especially in lethal castration-resistant prostate cancer (CRPC). However, the signaling pathways that regulate EZH2 functions in PCa remain incompletely defined. Using EZH2 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dejie, Ding, Liya, Wang, Liguo, Zhao, Yu, Sun, Zhifu, Karnes, R. Jeffrey, Zhang, Jun, Huang, Haojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747388/ https://www.ncbi.nlm.nih.gov/pubmed/26516927

Ejemplares similares

LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
por: Wang, Xin, et al.
Publicado: (2016)

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer
por: Zhao, Jingwen, et al.
Publicado: (2016)

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer
por: Wu, Changping, et al.
Publicado: (2015)

Regulatory Networks of LncRNA MALAT-1 in Cancer
por: Fu, Shijian, et al.
Publicado: (2020)

A novel biosensor for the ultrasensitive detection of the lncRNA biomarker MALAT1 in non-small cell lung cancer
por: Chen, Mei, et al.
Publicado: (2021)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer
por: Hu, Ju-Chuan, et al.
Publicado: (2021)

lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma
por: Xiao, Lei, et al.
Publicado: (2020)

Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance
por: Hou, Junhui, et al.
Publicado: (2023)

TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway
por: Zhao, Xing, et al.
Publicado: (2021)

LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization
por: Zhang, Xiaoli, et al.
Publicado: (2023)

Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network
por: Hao, Aixin, et al.
Publicado: (2021)

lncRNA MALAT1 Accelerates Skeletal Muscle Cell Apoptosis and Inflammatory Response in Sepsis by Decreasing BRCA1 Expression by Recruiting EZH2
por: Yong, Hui, et al.
Publicado: (2020)

lncRNA MALAT1 Accelerates Skeletal Muscle Cell Apoptosis and Inflammatory Response in Sepsis by Decreasing BRCA1 Expression by Recruiting EZH2
por: Yong, Hui, et al.
Publicado: (2019)

Role of lncRNA MALAT1 in UVA-induced corneal endothelial senescence
por: Qiao, Yujie, et al.
Publicado: (2023)

LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer
por: Zhang, Ali, et al.
Publicado: (2015)

LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer
por: Hao, Longhui, et al.
Publicado: (2023)

LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer
por: Zhou, Qinfeng, et al.
Publicado: (2018)

The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis
por: Elamir, Azza M., et al.
Publicado: (2021)

The Role of the lncRNA MALAT1 in Neuroprotection against Hypoxic/Ischemic Injury
por: Wang, Liping, et al.
Publicado: (2022)

Hydrogen inhibits the proliferation and migration of gastric cancer cells by modulating lncRNA MALAT1/miR-124-3p/EZH2 axis
por: Zhu, Baocheng, et al.
Publicado: (2021)

LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene
por: Zhao, Zhen, et al.
Publicado: (2021)

Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
por: Tai, Zongguang, et al.
Publicado: (2020)

Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer
por: Su, Min, et al.
Publicado: (2018)

Polycomb-independent activity of EZH2 in castration resistant prostate cancer
por: Xu, Kexin, et al.
Publicado: (2013)

Correction: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis
por: Sun, Rui, et al.
Publicado: (2023)

The role of lncRNA MALAT1 in the regulation of hepatocyte proliferation during liver regeneration
por: Li, Cuicui, et al.
Publicado: (2017)

Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus
por: Liu, J-Y, et al.
Publicado: (2014)

LncRNA expression profile during autophagy and Malat1 function in macrophages
por: Ma, Zhanbing, et al.
Publicado: (2019)

The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis
por: Xia, Hongwei, et al.
Publicado: (2016)

EPC‐derived exosomes promote osteoclastogenesis through LncRNA‐MALAT1
por: Cui, Yigong, et al.
Publicado: (2019)

lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell
por: Huang, Yongye, et al.
Publicado: (2021)

Cancer–Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer
por: Sebastian, Aimy, et al.
Publicado: (2015)

LncRNA LINC01512 Promotes the Progression and Enhances Oncogenic Ability of Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2017)

Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1
por: Jiang, Xia, et al.
Publicado: (2020)

Combining EZH2 and HDAC inhibitors to target castration-resistant prostate cancers
por: Coulter, Jonathan B., et al.
Publicado: (2023)

A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer
por: Gu, Peng, et al.
Publicado: (2019)

LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging
por: Zhang, Jun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ov0cj2pq0436vq4o3n9mc8k5bo